Time to engraftment defined as the first 3 consecutive days in which ANC >= 500 in both arms (standard myeloablative CBT with and without off-the-shelf expanded cord blood progenitors) Up to 2 years [clinicaltrials_resource:47683a2e2e1b2460a0b0eceb7ded2d32]
The log-rank test will be used. Groups will be compared using Gray's test.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Time to engraftment defined as the first 3 consecutive days in which ANC >= 500 in both arms (standard myeloablative CBT with and without off-the-shelf expanded cord blood progenitors) Up to 2 years [clinicaltrials_resource:47683a2e2e1b2460a0b0eceb7ded2d32]
The log-rank test will be used. Groups will be compared using Gray's test.
Bio2RDF identifier
47683a2e2e1b2460a0b0eceb7ded2d32
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:47683a2e2e1b2460a0b0eceb7ded2d32
measure [clinicaltrials_vocabulary:measure]
Time to engraftment defined as ...... panded cord blood progenitors)
time frame [clinicaltrials_vocabulary:time-frame]
Up to 2 years
description
The log-rank test will be used. Groups will be compared using Gray's test.
identifier
clinicaltrials_resource:47683a2e2e1b2460a0b0eceb7ded2d32
title
Time to engraftment defined as ...... ood progenitors) Up to 2 years
@en
type
label
Time to engraftment defined as ...... 83a2e2e1b2460a0b0eceb7ded2d32]
@en